Search research articles
Contact Us
Filters
Showing results (41-50 of 516) with videos related to
Page
of 52
Sort By:
Breast Cancer Research and Treatment
|
September 30, 2011
Dual HER2-targeted approaches in HER2-positive breast cancer
Eugene R Ahn, Charles L Vogel
Statistical Methods in Medical Research
|
November 8, 2001
Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients
J W Gamel, R L Vogel
Cancer Management and Research
|
January 19, 2019
Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Reshma L Mahtani, Charles L Vogel
The American Psychologist
|
April 27, 2002
The emperor's new clothes: sociopolitical diversity in psychology
Stephen R Wester, David L Vogel
Neuropeptides
|
March 1, 1995
Role of endogenous opioid peptides in central glucocorticoid receptor (GR)-induced decreases in circulating LH in the male rat
K P Briski, K L Vogel
Journal of Andrology
|
March 1, 1984
Orchiectomy in young rats results in differential regulation of follicle-stimulating hormone and luteinizing hormone content
D L Vogel, R J Sherins
Journal of Oncology Practice
|
November 19, 2016
Creating the Conditions for Implementing Team Principles in Cancer Care
Amanda L Vogel, Kara L Hall
Journal of Counseling Psychology
|
October 31, 2012
Assessing the utility of the willingness/prototype model in predicting help-seeking decisions
Joseph H Hammer, David L Vogel
Missouri Medicine
|
September 1, 1995
Tax-exempt integrated delivery systems: Part 2, Stark I and Stark II
P L Vogel, H M Cripps
Scandinavian Journal of Immunology
|
March 1, 1997
Characterization of components of the murine B cell receptor complex and their role in anti-Ig stimulation
L Vogel, M Götz, D Haustein
Page
of 52
Search research articles
Search
Showing results (41-50 of 516) with videos related to
Sort By:
Page
of 52
Breast Cancer Research and Treatment
|
September 30, 2011
Dual HER2-targeted approaches in HER2-positive breast cancer
Eugene R Ahn, Charles L Vogel
Statistical Methods in Medical Research
|
November 8, 2001
Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients
J W Gamel, R L Vogel
Cancer Management and Research
|
January 19, 2019
Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Reshma L Mahtani, Charles L Vogel
The American Psychologist
|
April 27, 2002
The emperor's new clothes: sociopolitical diversity in psychology
Stephen R Wester, David L Vogel
Neuropeptides
|
March 1, 1995
Role of endogenous opioid peptides in central glucocorticoid receptor (GR)-induced decreases in circulating LH in the male rat
K P Briski, K L Vogel
Journal of Andrology
|
March 1, 1984
Orchiectomy in young rats results in differential regulation of follicle-stimulating hormone and luteinizing hormone content
D L Vogel, R J Sherins
Journal of Oncology Practice
|
November 19, 2016
Creating the Conditions for Implementing Team Principles in Cancer Care
Amanda L Vogel, Kara L Hall
Journal of Counseling Psychology
|
October 31, 2012
Assessing the utility of the willingness/prototype model in predicting help-seeking decisions
Joseph H Hammer, David L Vogel
Missouri Medicine
|
September 1, 1995
Tax-exempt integrated delivery systems: Part 2, Stark I and Stark II
P L Vogel, H M Cripps
Scandinavian Journal of Immunology
|
March 1, 1997
Characterization of components of the murine B cell receptor complex and their role in anti-Ig stimulation
L Vogel, M Götz, D Haustein
Page
of 52